Zoetis Receives Contract Award to Supply the USDA’s National Veterinary Stockpile

with its Conditionally Licensed Avian Influenza Vaccine H5N1

FLORHAM PARK, N.J., June 9, 2016Zoetis Inc. today announced the U.S. Department of Agriculture (USDA) has awarded the company its latest contract for vaccines that could be used against avian influenza. The contract calls for 34.2 million doses of Avian Influenza Vaccine, H5N1 Subtype, Killed Virus*, valued at $3.42 million, to be delivered in 2016 and for another 34.2 million doses, valued at $3.42 million, to be delivered in 2017. The USDA granted Zoetis a conditional license for this vaccine, intended for use in chickens as an aid in the prevention of disease caused by avian influenza virus H5N1, in March 2016.

“Developing this newest vaccine is further demonstration of our strong commitment to poultry producers,” said Jon Schaeffer, DVM, Director of U.S. Poultry Veterinary Services at Zoetis. “We stand ready to help implement a vaccination strategy, should the USDA determine that is the best course of action for the industry. In the meantime, we continue to support the USDA and our customers in helping prevent future avian influenza outbreaks.”

An outbreak of highly pathogenic avian influenza (HPAI) during the spring and summer of 2015 was the largest animal health emergency in the country’s history, according to USDA. More than 49 million birds have died, with HPAI detected in migratory birds as well as commercial and backyard flocks in 21 states, as a result of last year’s outbreak1.

The conditional license was granted on the demonstration of a reasonable expectation of efficacy based on serology data. For more information about this announcement, please reach out to your Zoetis representative.

*This product license is conditional. Efficacy and potency studies are in progress.

About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For Further details contact:
Christina Lood
(973) 822-7249


1 2016 HPAI Preparedness and Response Plan USDA APHIS. https://www.aphis.usda.gov/animal_health/downloads/animal_diseases/ai/hpai-preparedness-and-response-plan-2015.pdf Page 3. Accessed March 1, 2016.



Mon–Fri, 8:30am–6:30pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.